BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22520134)

  • 1. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.
    Patel M; Steele AD; Parashar UD
    Vaccine; 2012 Apr; 30 Suppl 1():A30-5. PubMed ID: 22520134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
    Cowley D; Sari RM; Handley A; Watts E; Bachtiar NS; At Thobari J; Satria CD; Bogdanovic-Sakran N; Nirwati H; Orsini F; Lee KJ; Kirkwood CD; Soenarto Y; Bines JE
    Vaccine; 2019 Nov; 37(49):7233-7239. PubMed ID: 31607604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems.
    Kirkpatrick BD; Colgate ER; Mychaleckyj JC; Haque R; Dickson DM; Carmolli MP; Nayak U; Taniuchi M; Naylor C; Qadri F; Ma JZ; Alam M; Walsh MC; Diehl SA; ; Petri WA
    Am J Trop Med Hyg; 2015 Apr; 92(4):744-51. PubMed ID: 25711607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
    Emperador DM; Velasquez DE; Estivariz CF; Lopman B; Jiang B; Parashar U; Anand A; Zaman K
    Clin Infect Dis; 2016 Jan; 62(2):150-6. PubMed ID: 26349548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
    Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
    Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polio endgame: Lessons for the global rotavirus vaccination program.
    Jiang B; Patel M; Glass RI
    Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Ward RL; Mack ME; Zito ET
    J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
    Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
    Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age.
    Zaman K; Sack DA; Yunus M; Arifeen SE; Podder G; Azim T; Luby S; Breiman RF; Neuzil K; Datta SK; Delem A; Suryakiran PV; Bock HL;
    Vaccine; 2009 Feb; 27(9):1333-9. PubMed ID: 19162114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of rotavirus in India--is rotavirus vaccine an answer to it?
    Taneja DK; Malik A
    Indian J Public Health; 2012; 56(1):17-21. PubMed ID: 22684168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to improve oral vaccine performance: a systematic review and meta-analysis.
    Church JA; Parker EP; Kirkpatrick BD; Grassly NC; Prendergast AJ
    Lancet Infect Dis; 2019 Feb; 19(2):203-214. PubMed ID: 30712836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.
    Tregnaghi MW; Abate HJ; Valencia A; Lopez P; Da Silveira TR; Rivera L; Rivera Medina DM; Saez-Llorens X; Gonzalez Ayala SE; De León T; Van Doorn LJ; Pilar Rubio MD; Suryakiran PV; Casellas JM; Ortega-Barria E; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2011 Jun; 30(6):e103-8. PubMed ID: 21378594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
    Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.